FindTrial
Sign In

Studying the role of a fetal membranes for treatment of decayed teeth in the mouth.

Amniotic membrane as a therapeutic agent for pulpotomy in permanent molars: A Randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045227
Enrollment
24
Registered
2022-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: Amnion (AM): Amniotic membrane procured as a freeze-dried gamma-irradiated graft from the tissue bank of Tata Memorial hospital(Mumbai) will be placed inside the pulp cavity of the teet

Sponsors

Saumya Johri
Lead Sponsor
Dr Promila Verma
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients between the age 18-35 years who give written consent to participate in the study. 2) Permanent molars having pulp exposure due to deep caries.

Exclusion criteria

Exclusion criteria: 1) Immature teeth 2) Patients showing clinical signs and symptoms of abscess/fistula, tenderness on percussion, and mobility. 3) Teeth showing radiographic signs of periapical pathology, furcation pathology and/or resorption. 4) Non-vital teeth.

Design outcomes

Primary

MeasureTime frame
Clinical success of pulpotomy. Evaluated by absence of signs and symptoms such as pain, inflammation, abscess/sinus, mobility, and crown failureTimepoint: 1, 3 and 9 months—

Secondary

MeasureTime frame
Radiographical success of pulpotomy. Evaluated by evaluating for pathological internal or external resorption, presence of calcifications and integrity of lamina duraTimepoint: 1, 3 and 9 months—

Countries

India

Contacts

Public ContactPromila Verma

KGMU

saumya.johry@gmail.com8840854587

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026